Skip to main content

NUEVAS APROXIMACIONES TERANOSTICAS EN HIPERTENSION PULMONAR: INTERVENCIONES EN EL ESTILO DE VIDA

PID2021-123238OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2021
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre ASOCIACIÓN CENTRO DE INVESTIGACION COOP. BIOMATERIALES

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Radiolabeled Iron Oxide Nanomaterials for Multimodal Nuclear Imaging and Positive Contrast Magnetic Resonance Imaging (MRI): A Review

  • Pellico, Juan
  • Ruíz-Cabello, Jesús
  • Herranz, Fernando
Iron oxide nanoparticles (IONP) have been hailed as potential game-changers in biomedical imaging owing to their biocompatibility and size-dependent properties. One area where IONP has shown particular promise is magnetic resonance imaging (MRI), which traditionally uses superparamagnetic nanomaterials to produce negative contrast that darkens the tissues where nanoparticles accumulates. Unfortunately, this hypointense signal is a major drawback for clinical applications because it can make it difficult to identify the accumulated probes. As a result, researchers are exploring alternative options that can incorporate the advantages of IONP while also possessing valuable properties for molecular imaging. To achieve this goal, the most effective method involves not only utilizing positive contrast in MRI applications but also combining IONP with the unparalleled sensitivity of nuclear imaging techniques, for example, using radioisotopes to create PET/(T)MRI multimodal probes. To create such probes, various factors must be considered, including the radiolabeling strategy employed and overall complexity of the final nanoprobe. These nanoradiomaterials offer novel possibilities that span beyond the molecular imaging field, showing potential for the development of radiopharmaceuticals and theranostics., This study was supported by the Spanish Ministry of Science and Innovation (PID2019-104059RB-I00, PDC2022-133493- I00, PID2021-123238OB-I00), Comunidad de Madrid (S2022/BMD-7333) and La Caixa Foundation (Health Research Call 2020: HR20-00075).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Lipid-based nanomedicines for the treatment of bacterial respiratory infections: current state and new perspectives

  • Arroyo-Urea, Eva María
  • Lázaro-Díez, María
  • Garmendia, Juncal
  • Herranz, Fernando
  • González-Paredes, Ana
The global threat posed by antimicrobial resistance demands urgent action and the development of effective drugs. Lower respiratory tract infections remain the deadliest communicable disease worldwide, often challenging to treat due to the presence of bacteria that form recalcitrant biofilms. There is consensus that novel anti-infectives with reduced resistance compared with conventional antibiotics are needed, leading to extensive research on innovative antibacterial agents. This review explores the recent progress in lipid-based nanomedicines developed to counteract bacterial respiratory infections, especially those involving biofilm growth; focuses on improved drug bioavailability and targeting and highlights novel strategies to enhance treatment efficacy while emphasizing the importance of continued research in this dynamic field., This work was supported by Atracción de Talento program (Modalidad 1) from Comunidad de Madrid (Spain) (Reference 2019-T1/IND-12906), Nanomedicine CSIC Hub (Spain) funding (PIE 202180E048), Spanish Ministry of Science and Innovation (PID2021-123238OB-I00, PID2021-125947OB-I00, PDC2022-133493-I00, RED2022-134299-T), Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) (875/2019), Gobierno de Navarra (Spain) (PC150, PC136) and Comunidad de Madrid (Spain) (P2022/BMD-7333). CIBER is an initiative from Instituto de Salud Carlos III (ISCIII) (Spain). EM Arroyo-Urea benefits from the FPU fellowship program of the Spanish Ministry of Universities (reference FPU21/04116). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed